Tremelimumab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration

NCT07307456 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Treatment with toripalimab combined with BCG perfusion following transurethral resection of bladder tumor (TURBT)

Sponsor

Changhai Hospital